Joshua Maher

610 total citations · 1 hit paper
10 papers, 451 citations indexed

About

Joshua Maher is a scholar working on Molecular Medicine, Pharmacology and Endocrinology. According to data from OpenAlex, Joshua Maher has authored 10 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 4 papers in Pharmacology and 3 papers in Endocrinology. Recurrent topics in Joshua Maher's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Salmonella and Campylobacter epidemiology (2 papers). Joshua Maher is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Salmonella and Campylobacter epidemiology (2 papers). Joshua Maher collaborates with scholars based in United States, Israel and Japan. Joshua Maher's co-authors include Shivani Ghaisas, Anumantha G. Kanthasamy, Sara E. Gragg, Mariana Castanheira, Leonardo M. Bastos, Peter W. Cook, Rodrigo E. Mendes, Manreet Bhullar, Valentina Trinetta and Sara Lomonaco and has published in prestigious journals such as Frontiers in Microbiology, Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Joshua Maher

10 papers receiving 439 citations

Hit Papers

Gut microbiome in health and disease: Linking the microbi... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua Maher United States 5 274 123 74 67 41 10 451
Rashad Alkasir China 9 271 1.0× 137 1.1× 87 1.2× 64 1.0× 51 1.2× 12 526
Zahra Karimitabar Iran 4 216 0.8× 104 0.8× 93 1.3× 31 0.5× 25 0.6× 8 367
Lisa Till United States 4 318 1.2× 105 0.9× 74 1.0× 56 0.8× 72 1.8× 8 456
Boris Kovarsky Russia 5 272 1.0× 98 0.8× 63 0.9× 28 0.4× 42 1.0× 9 416
Yiwen Cheng China 13 537 2.0× 163 1.3× 140 1.9× 79 1.2× 122 3.0× 23 809
Panida Sittipo South Korea 11 493 1.8× 155 1.3× 76 1.0× 84 1.3× 82 2.0× 13 777
Veronica Madau Italy 5 409 1.5× 267 2.2× 63 0.9× 45 0.7× 50 1.2× 5 589
E. Kuijper Netherlands 3 278 1.0× 94 0.8× 65 0.9× 23 0.3× 121 3.0× 5 367

Countries citing papers authored by Joshua Maher

Since Specialization
Citations

This map shows the geographic impact of Joshua Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Maher more than expected).

Fields of papers citing papers by Joshua Maher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Maher. The network helps show where Joshua Maher may publish in the future.

Co-authorship network of co-authors of Joshua Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Maher. A scholar is included among the top collaborators of Joshua Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Maher. Joshua Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Papp‐Wallace, Krisztina M., Hélio S. Sader, Joshua Maher, John H. Kimbrough, & Mariana Castanheira. (2025). Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017–2022). Open Forum Infectious Diseases. 12(5). ofaf250–ofaf250. 1 indexed citations
3.
Kimbrough, John H., Joshua Maher, Hélio S. Sader, Mariana Castanheira, & Rodrigo E. Mendes. (2024). In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals. Microbiology Spectrum. 12(11). e0147424–e0147424. 5 indexed citations
4.
5.
Maher, Joshua, et al.. (2023). Impact of the Probiotic Organism Megasphaera elsdenii on Escherichia coli O157:H7 Prevalence in Finishing Cattle. Journal of Food Protection. 86(9). 100133–100133. 3 indexed citations
6.
DeJonge, Boudewijn L, Sean Nguyen, Joshua Maher, et al.. (2023). 2761. Activity of Cefiderocol and Comparator Agents Against Achromobacter and Burkholderia Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
Maher, Joshua, Rodrigo E. Mendes, Holly K. Huynh, et al.. (2022). In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections. The Pediatric Infectious Disease Journal. 42(3). 206–211. 3 indexed citations
8.
Lomonaco, Sara, Leonardo M. Bastos, Peter W. Cook, et al.. (2021). Genotypic and Phenotypic Characterization of Antimicrobial Resistance Profiles in Non-typhoidal Salmonella enterica Strains Isolated From Cambodian Informal Markets. Frontiers in Microbiology. 12. 711472–711472. 26 indexed citations
10.
Ghaisas, Shivani, Joshua Maher, & Anumantha G. Kanthasamy. (2015). Gut microbiome in health and disease: Linking the microbiome–gut–brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacology & Therapeutics. 158. 52–62. 399 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026